Every 10-Q that Community Health Systems, Inc. (CYH) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow CYH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CYH filings page.
Community Health Systems, Inc., which operates 60 affiliated hospitals with more than 8,000 beds and over 800 sites of care in 32 markets across 12 states, reported softer results for the quarter ended June 30, 2026. Net operating revenues were $2,825 million versus $3,133 million a year earlier, while net income attributable to stockholders was $70 million, or $0.51 per diluted share, down from $282 million, or $2.09 per share. On a same-store basis, quarterly net operating revenues increased $65 million, same-store inpatient admissions rose 1.9% and same-store adjusted admissions grew 2.9%, but consolidated admissions declined 11.4% following hospital divestitures.
During the first half of 2026, the company divested eight hospitals and sold its 80% interest in one Tennessee hospital that together generated approximately $1.6 billion of 2025 net operating revenues, receiving about $1.2 billion of net proceeds. These transactions produced a $262 million net gain, partly offset by $131 million of impairment charges, and were used alongside cash to redeem and repurchase portions of several senior secured notes, reducing total debt to $9,578 million from $10,396 million at year-end 2025.
For the six months ended June 30, 2026, operations used $209 million of cash, compared with $208 million provided in the prior-year period, even as investing activities generated $1,000 million of cash, largely from divestitures. Charity care expanded after policy changes: foregone revenue at standard charges was $519 million in the quarter, 18.3% of net operating revenues, and the related cost was $50 million. The company remains in a stockholders’ deficit position, with total liabilities of $13,021 million exceeding assets of $12,177 million.
Community Health Systems, Inc. reported net operating revenues of $2.965 billion for the quarter ended March 31, 2026, down from $3.159 billion a year earlier, though same-store revenues rose modestly. The company posted a net loss attributable to stockholders of $58 million, compared with a $13 million loss in the prior-year quarter, as higher taxes and interest outweighed operating gains and divestiture benefits.
Cash and cash equivalents increased to $712 million, driven largely by $657 million of proceeds from the sale of three Pennsylvania hospitals and an 80% interest in a Tennessee hospital, plus a subsequent $459 million Crestwood Medical Center sale completed April 1, 2026. Community Health Systems continues to reshape its portfolio, classifying additional Arkansas hospitals as held-for-sale, while managing a significant $10.156 billion debt load and negative operating cash flow of $297 million this quarter.
Community Health Systems (CYH) reported a return to profitability in Q3 2025. Net operating revenues were $3,087 million, essentially flat year over year. Income from operations was $243 million versus a loss of $205 million a year ago. Net income attributable to stockholders was $130 million, or $0.96 diluted EPS, compared with a loss of $391 million, or $(2.95) diluted EPS.
For the nine months, revenues were $9,379 million and net income attributable to stockholders was $399 million, or $2.97 diluted EPS, versus a loss of $446 million, or $(3.38) diluted EPS, last year. Results reflect a net gain of approximately $242 million from divestitures year to date and a Q3 income tax benefit of about $163 million tied to federal legislation. Interest expense was $216 million in Q3.
Cash from operations reached $277 million year to date. Asset sales provided $1,012 million of proceeds. Long‑term debt declined to $10,589 million from $11,432 million at year‑end, supported by refinancing, including $700 million of 10.75% senior secured notes due 2033 and $1.790 billion of 9.75% senior secured notes due 2034, alongside tenders/redemptions of 2027 and 2028 notes.